Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127892521 | 12789252 | 1 | I | 20160914 | 20160928 | 20160928 | EXP | DE-SHENZHEN TECHDOW PHARMACEUTICAL CO. LTD-DE-2016TEC0000029 | SHENZHEN TECHDOW PHARMACEUTICAL | DIEHL C, HAUX D, SAHM F, UNTERBERG AW, BEYNON C.. INTRACRANIAL TUMOUR HAEMORRHAGE FOLLOWING INTRAVENOUS THROMBOLYSIS. J CLIN NEUROSCI. 2016;145-146 | 58.00 | YR | M | Y | 0.00000 | 20160927 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127892521 | 12789252 | 1 | PS | Heparin Sodium Injection USP, Preservative Free | HEPARIN SODIUM | 1 | Intravenous (not otherwise specified) | 5000 IU, UNK | U | 202732 | 5000 | IU | INJECTION | ||||||
| 127892521 | 12789252 | 2 | SS | Heparin Sodium Injection USP, Preservative Free | HEPARIN SODIUM | 1 | U | 202732 | INJECTION | ||||||||||
| 127892521 | 12789252 | 3 | SS | ALTEPLASE | ALTEPLASE | 1 | Intravenous (not otherwise specified) | 100 MG, UNK | U | 0 | 100 | MG | |||||||
| 127892521 | 12789252 | 4 | SS | ALTEPLASE | ALTEPLASE | 1 | U | 0 | |||||||||||
| 127892521 | 12789252 | 5 | SS | ASPIRIN /00002701/ | ASPIRIN | 1 | Intravenous (not otherwise specified) | 500 MG, UNK | U | 0 | 500 | MG | |||||||
| 127892521 | 12789252 | 6 | SS | ASPIRIN /00002701/ | ASPIRIN | 1 | U | 0 | |||||||||||
| 127892521 | 12789252 | 7 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 150 MG, UNK | U | 0 | 150 | MG | |||||||
| 127892521 | 12789252 | 8 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127892521 | 12789252 | 1 | Electrocardiogram ST segment elevation |
| 127892521 | 12789252 | 2 | Antiplatelet therapy |
| 127892521 | 12789252 | 3 | Electrocardiogram ST segment elevation |
| 127892521 | 12789252 | 4 | Thrombolysis |
| 127892521 | 12789252 | 5 | Electrocardiogram ST segment elevation |
| 127892521 | 12789252 | 6 | Antiplatelet therapy |
| 127892521 | 12789252 | 7 | Electrocardiogram ST segment elevation |
| 127892521 | 12789252 | 8 | Antiplatelet therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127892521 | 12789252 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127892521 | 12789252 | Depressed level of consciousness | |
| 127892521 | 12789252 | Haemorrhage intracranial | |
| 127892521 | 12789252 | Hemiparesis | |
| 127892521 | 12789252 | Intracranial haematoma | |
| 127892521 | 12789252 | Intracranial tumour haemorrhage | |
| 127892521 | 12789252 | Intraventricular haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |